Citations

Showing 10 of 108094 citations.

Radiographic Risk Factors and Signs of Abductor Tears in the Hip
Hartigan, David E. , Perets, Itay , Walsh, John P. , Mohr, Mitchell R., Chaharbakhshi, Edwin O., Yuen, Leslie C. , Domb, Benjamin G.

Mayo Clinic

Arthroscopy | July 7, 2018 | Volume: 34 | Issue: 8 | Pages: 2389-2397

10.1016/j.arthro.2018.03.039 | PMID 30078428 Get It

Purpose The purpose of this study is to identify radiographic risk factors (RRFs) and radiographic signs of abductor tendon tears. Methods Between April 2008 and October 2015, patients with intraoperative diagnosis of partial‐ or full‐thickness abductor tear noted at the time of open or endoscopic treatment were included in this study. Exclusion criteria included lack of preoperative standard supine pelvic radiograph, lack of preoperative magnetic resonance imaging (MRI), or abductor tear not present at the time of operative intervention. Patients were matched by age ±5 years, gender, and body mass index ±5 with patients with no abductor pathology by clinical exam and MRI. A standardized supine anterior‐posterior pelvis radiograph was performed on all patients. The radiographs were evaluated for RRF (pelvic width, body weight moment arm, abductor moment arm, abductor angle, pelvic height) and signs of abductor tendon pathology (greater trochanteric enthesophyte). Femoral version was measured on MRI when images were available. Statistical analysis was performed and included bivariate and multivariate analyses. Results There were 152 patients with abductor tears identified at the time of surgery out of 2,838 eligible patients matched with 125 patients without abductor tendon pathology. The study institution was unable to perform a 1:1 match because of the advanced age of the abductor tendon group, which led to a greater age in the abductor group ( n = 58) versus the control group ( n = 54; P = .01. In abductor group the average age was 58, and 137 of 152 (90%) patients were female; in the control group the average age was 54, with 111 of 125 (89%) patients being female. Abductor tear patients were treated with surgical repair. The RRFs found with bivariate analysis were an increased pelvic width (14.8 cm for abductor tears vs 14.3 cm for control; P < .001), body weight moment arm (11.1 cm vs 10.9 cm; P < .001), and abductor moment arm (7.8 cm vs 7.6 cm; P < .001); decreased femoral anteversion (7.6° vs 10.6°; P = .045); and enthesophyte presence (41% vs 3%; P < .001). Multivariate regression analysis of all variables showed that teardrop distance and enthesophyte presence were the 2 variables most predictive of abductor tears, and other variables did not significantly increase or decrease the likelihood of tear when these 2 variables were considered. The presence of an enthesophyte on the greater trochanter was notable for an odds ratio of 20.7 of having an abductor tear. Conclusions Patients with abductor tears have a wider pelvis, longer abductor moment arm, and longer body weight moment arm and have greater trochanteric enthesophyte as noted on nearly half of patients with an abductor tear. Presence of an enthesophyte was noted to have an odds ratio of 20.7 and a positive predictive value of 94% for having an abductor tendon tear. The 2 variables predictive of abductor tendon tear when controlling for all variables were enthesophyte presence and teardrop distance, with no other variables significantly increasing or decreasing the likelihood of tear when these 2 variables were considered. Level of Evidence Level III, retrospective comparative study.
Responses to Topical Diphenylcyclopropenone as an Adjunct Treatment for In-Transit Melanoma: A Tertiary Referral Center Experience
Veverka, Kevin K. , Jakub, James W. , Baum, Christian L. , Jakub, James W

Mayo Clinic

Dermatologic Surgery | July 7, 2018 | Volume: 44 | Issue: 12 | Pages: 1501-1508

10.1097/dss.0000000000001603 | PMID 29985863 Get It

BACKGROUND In-transit cutaneous metastases occur in 5% to 10% of patients with melanoma. Recently, topical diphenylcyclopropenone (DPCP) has been described as a treatment option. OBJECTIVE To evaluate efficacy of DPCP in treatment of in-transit cutaneous melanoma. METHODS The authors retrospectively reviewed the records of 13 consecutive patients with in-transit metastases treated with topical DPCP between March 1, 2013, and January 31, 2017. The authors recorded the response of in-transit cutaneous melanoma lesions treated with DPCP measured by clinical examination. RESULTS Among the 13 patients, 9 patients completed at least a 1-month course of DPCP treatment. Of these 9 patients, 6 (66.7%) maintained either stable disease or had a partial or complete regression, and 3 (33.3%) had progressive disease. Patients with less burden of disease (e.g., <15 lesions) responded more favorably than those with a greater burden of disease (e.g., >25 lesions or plaques). Both patients who received DPCP alone had progression of their cutaneous lesions. One patient who did not become sensitized to DPCP died within 2 months, and his anergy likely reflecting immense burden of disease. CONCLUSION Topical DPCP is a low-cost, patient-applied treatment option for in-transit melanoma, most effective for patients with relatively low tumor burden and localized disease.
Echocardiography in transcatheter aortic (Core)Valve implantation: Part 2—Transesophageal echocardiography
Naqvi, Tasneem Z.

Mayo Clinic

Echocardiography | July 7, 2018 | Volume: 35 | Issue: 7 | Pages: 1020-1041

10.1111/echo.14034 | PMID 29981214 Get It

Transesophageal echocardiography (TEE) plays a significant role during transcatheter aortic valve implantation (TAVR). 2DTEE allows assessment of anatomy of the aortic valve, aortic root, left ventricular (LV) outflow tract, severity of the aortic valve stenosis (AS), and the presence and severity of other valve stenosis and regurgitation. Left and right ventricular size and global function as well as cardiac hemodynamics pre and post TAVR and LV regional wall motion can be assessed. Three‐dimensional (3D) imaging adds significantly via accurate measurement of aortic annulus that helps select the appropriate valve size. Biplane imaging allows simultaneous assessment of target cardiac structure in two orthogonal views and provides a rapid assessment during and immediately post valve deployment by evaluating stent height, leaflet motion, and the presence and severity of paravalvular leak (PVL). 2DTEE and 3DTEE allow evaluation of mechanism of PVL that helps guide the decision regarding need for balloon post dilation of the implanted valve or valve in valve implantation.
Mexiletine rescues a mixed biophysical phenotype of the cardiac sodium channel arising from the SCN5A mutation, N406K, found in LQT3 patients
Hu, Rou-Mu, Tester, David J. , Li, Ryan , Sun, Tianyu , Peterson, Blaise Z., Ackerman, Michael J. , Makielski, Jonathan C., Tan, Bi-Hua, Li, Ryan, Tan, Bi‐Hua

Mayo Clinic

Channels | July 7, 2018 | Volume: 12 | Issue: 1 | Pages: 176-186

10.1080/19336950.2018.1475794 | PMID 29983085 Get It

Features of Adult Hyperammonemia Not Due to Liver Failure in the ICU
Sakusic, Amra , Sabov, Moldovan, McCambridge, Amanda, Singh, Tarun D. , Mukesh, Kumar, Gajić, Ognjen, McCambridge, Amanda J, Rabinstein, Alejandro A. , Kashani, Kianoush , Cook, David J. , Gajic, Ognjen

Mayo Clinic

Critical Care Medicine | July 7, 2018 | Volume: 46 | Issue: 9 | Pages: e897-e903

10.1097/ccm.0000000000003278 | PMID 29985210 Get It

Objectives: To evaluate the epidemiology of hyperammonemia unrelated to liver failure in the critical care setting. Design: Retrospective case series. Setting: Critically ill patients admitted to ICUs at Mayo Clinic, Rochester, MN (medical ICU, two mixed medical-surgical ICUs, coronary care unit, or the cardiosurgical ICU) between July 1, 2004, and October 31, 2015. Patients: Adult critically ill patients with hyperammonemia not related to acute or chronic liver failure. We excluded patients with diagnosis of moderate or severe liver disease, hyperbilirubinemia, and patients who denied the use of their medical records. Interventions: None. Measurements and Main Results: Of 3,908 ICU patients with hyperammonemia, 167 (4.5%) had no evidence of acute or chronic liver failure. One-hundred one patients (60.5%) were male with median age of 65.7 years (interquartile range, 50–74.5 yr) and median serum ammonia level of 68 µg/dL (interquartile range, 58–87 µg/dL). Acute encephalopathy was present in 119 patients (71%). Predisposing conditions included malnutrition 27 (16%), gastric bypass six (3.6%), total parenteral nutrition four (2.4%); exposure to valproic acid 17 (10%); status epilepticus 11 (6.6%), high tumour burden 19 (11.3%), and renal failure 82 (49.1%). Urea cycle defects were diagnosed in seven patients (4.1%). Hospital mortality was high (30%), and median ammonia level was higher among the nonsurvivors (74 vs 67 µg/dL; p = 0.05). Deaths were more likely in hyperammonemic patients who were older (p = 0.016), had greater illness severity (higher Acute Physiology and Chronic Health Evaluation III score, p < 0.01), malignancy (p < 0.01), and solid organ transplantation (p = 0.04), whereas seizure disorder was more common in survivors (p = 0.02). After adjustment, serum ammonia level was not associated with increased mortality. Conclusions: Hyperammonemia occurs in a substantial minority of critically ill patients without liver failure. These patients have a poor prognosis, although ammonia level per se is not independently associated with mortality. Serum ammonia should be measured when risk factors are present, such as nutritional deficiencies and protein refeeding, treatment with valproic acid, high tumour burden, and known or suspected urea cycle abnormalities.
Outcomes in Patients With Severe West Nile Neuroinvasive Disease
Carabenciov, Ivan D. , Hawkes, Maximiliano A. , Wijdicks, Eelco F. M. , Rabinstein, Alejandro A.

Mayo Clinic

Critical Care Medicine | July 7, 2018 | Volume: 46 | Issue: 9 | Pages: e955-e958

10.1097/ccm.0000000000003257 | PMID 29985213 Get It

Objective: To assess the long-term outcomes of patients hospitalized with severe West Nile neuroinvasive disease. Design: Retrospective cohort. Setting: Patients admitted to a referral center (Saint Mary’s Hospital, Mayo Clinic). Participants: Twenty-six patients with West Nile neuroinvasive disease were identified by retrospective search of electronic database of Saint Mary’s Hospital from January 1999 to November 2016. Interventions: Retrospective electronic medical records review and prospective telephone follow-up. Measurements and Main Results: Functional disability and cognitive outcomes were evaluated with the modified Rankin Scale and the Telephone Interview for Cognitive Status scores. Data on the time that the patient returned home after the hospitalization for West Nile neuroinvasive disease and the time of return to work were also collected. We identified 26 patients (81% males), 59 ± 17 years old. After a median hospital stay of 14.5 days (3–126), four patients died and 90% of survivors had a modified Rankin Scale of 3–5. Two additional patients died, and 80% of survivors had a modified Rankin Scale of 0–2 after a median follow-up of 73 months (1–144). Seven patients had cognitive impairment, which was severe in two of them. The combination of encephalitis and acute flaccid paralysis at presentation was associated with lower likelihood of returning home within 1 month after discharge (p < 0.01). Patients who required mechanical ventilation were more likely to have a modified Rankin Scale of 3–5 at last follow-up (p = 0.03), less likely to return home within 1 month of discharge (p < 0.01), less likely to return to their jobs (p < 0.01), and showed a trend toward having cognitive impairment (p = 0.05). Conclusions: Despite having poor outcomes at discharge, most West Nile neuroinvasive disease survivors with severe early disability can recover functional independence in the long term, justifying aggressive support during the acute phase and extensive rehabilitation efforts.
Impact of aging on diaphragm muscle function in male and female Fischer 344 rats
Khurram, Obaid U. , Fogarty, Matthew J. , Sarrafian, Tiffany L. , Bhatt, Arjun , Mantilla, Carlos B. , Sieck, Gary C. , Khurram, Obaid U , Fogarty, Matthew J

Mayo Clinic

Physiological Reports | July 7, 2018 | Volume: 6 | Issue: 13 | Pages: e13786

10.14814/phy2.13786 | PMID 29981218 Get It

Single dose versus multiple doses of rituximab for preemptive therapy of Epstein–Barr virus reactivation after hematopoietic cell transplantation
Jain, Tania , Grys, Thomas E. , Kung, Shu Ting, Shah, Vishal , Betcher, Jeffrey, Slack, James L., Leis, José F., Khera, Nandita , Noël, Pierre, Palmer, Jeanne , Sproat, Lisa Z., Shah, Vishal S, Betcher, Jeffrey A, Palmer, Jeanne M., Jain, Tania , Kosiorek, Heidi , Shah, Vishal , Grys, Thomas E

Mayo Clinic

Leukemia & Lymphoma | July 6, 2018 | Volume: 60 | Issue: 1 | Pages: 110-117

10.1080/10428194.2018.1459603 | PMID 29979906 Get It

Faculty Opinions recommendation of Microglia remodel synapses by presynaptic trogocytosis and spine head filopodia induction.
Wu, Long‐Jun , Eyo, Ukpong B

Mayo Clinic

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | July 6, 2018 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.732907490.793547771 Get It

Percutaneous Computed Tomography-Guided Radiotracer-Assisted Localization of Difficult Pulmonary Nodules in Uniportal Video-Assisted Thoracic Surgery
Dailey, Wesley A., Frey, G. , McKinney, J. Mark , Paz‐Fumagalli, Ricardo , Sella, David M., Toskich, Beau , Thomas, Mathew , Thomas, Mathew , Frey, Gregory T, Toskich, Beau B. , Thomas, Mathew

Mayo Clinic

Journal of Laparoendoscopic & Advanced Surgical Techniques | July 6, 2018 | Volume: 28 | Issue: 12 | Pages: 1451-1457

10.1089/lap.2018.0248 | PMID 29979620 Get It